For example, small molecules, such as 2-APQC and C12, that enhance SIRT3 activity, have shown promise in protecting against cardiac hypertrophy, neurodegeneration, and metabolic disorders in animal models [172, 173]. Here, SIRT3 is linked to cardiac hypertrophy.